Lidanserin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lidanserin
Lidanserin structure.png
Systematic (IUPAC) name
4-(3-{3-[4-(4-fluorobenzoyl)-1-piperidinyl]propoxy}-4-methoxyphenyl)-2-pyrrolidinone
Clinical data
Legal status ?
Identifiers
CAS number 73725-85-6
ATC code None
PubChem CID 68919
ChemSpider 62146
Chemical data
Formula C26H31FN2O4 
Mol. mass 454.534 g/mol

Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.[1][2] It was developed as an antihypertensive agent but was never marketed.[1][2]

See also[edit]

References[edit]

  1. ^ a b Richard C. Allen (1989). Annual Reports in Medicinal Chemistry. Academic Press. p. 56. ISBN 978-0-12-040524-4. Retrieved 6 May 2012. 
  2. ^ a b American Chemical Society; American Chemical Society. Chemical Abstracts Service (27 February 1989). Chemical abstracts. American Chemical Society. p. 114. Retrieved 6 May 2012.